Health

News Hour: Zika, dengue fever and chikungunya), have raised the global risk of yellow fever. Two large yellow fever outbreaks- in Angola and the Democratic Republic of Congo are now under control but these are just...

News Hour:   The U.S. Food and Drug Administration (FDA) has accepted for priority review the Biologics License Application (BLA) for dupilumab for the treatment of adult patients with inadequately controlled moderate-to-severe atopic dermatitis (AD), a serious,...

News Hour: Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs.  Sanofi and its vaccines global business unit Sanofi Pasteur announced  that the Biomedical Advanced Research and Development Authority (BARDA)...

News Hour: Dermatitis, also known as eczema, is a group of diseases that result in inflammation of the skin. They are characterized by itchiness and red skin.French drugmaker Sanofi (SASY.PA) and its U.S. partner Regeneron Pharmaceuticals (REGN.O) could win...

News Hour: A group of 40 investors managing $1.25 trillion in assets have launched a campaign to encourage 16 global food companies to change the way they source protein for their products to help to reduce...

News Hour: Stroke survivors may spend more time at home – as opposed to a nursing home or a hospital – if they were treated at a place that handles a lot of stroke patients or...

News Hour: The U.S. Food and Drug Administration on Friday approved Amgen Inc’s biosimilar version of AbbVie’s top-selling arthritis drug, Humira. The drug, Amjevita, known also as adalimumab-atto, was approved to treat rheumatoid arthritis, psoriatic arthritis,...

News Hour: Obstacle course runs like Tough Mudder and Warrior Dash are becoming more popular and are relatively safe for participants, a Canadian study suggests. Only about 1 percent of participants are injured during these races,...

News Hour: The unprecedented aerial spraying of products that kill both adult mosquitoes as well as their larvae delivered a “1-2 punch” that has stopped direct transmission of the Zika virus in the Wynwood section of...

News Hour When Mylan NV recruited food allergy bloggers to learn about its campaign to get allergic shock antidotes into schools, many were eager to join the maker of the EpiPens they carry in purses and...